This company seems to have been delisted
Reason: Acquired by Alcon
Last recorded trade on: January 20, 2023
Source: https://investor.alcon.com/news-and-events/press-releases/news-details/2022/Alcon-Completes-Acquisition-of-Aerie-Pharmaceuticals-Inc.-Strengthening-Companys-Ophthalmic-Pharmaceutical-Business/default.aspx
Reason: Acquired by Alcon
Last recorded trade on: January 20, 2023
Source: https://investor.alcon.com/news-and-events/press-releases/news-details/2022/Alcon-Completes-Acquisition-of-Aerie-Pharmaceuticals-Inc.-Strengthening-Companys-Ophthalmic-Pharmaceutical-Business/default.aspx
Aerie Pharmaceuticals
AERI
$20.45
Share price
0.00%
Change (1 day)
83.14%
Change (1 year)
Categories
Operating Margin for Aerie Pharmaceuticals (AERI)
Operating Margin as of March 2025 (TTM): -10.86%
According to Aerie Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -10.86%. At the end of 2021 the company had an Operating Margin of -38.23%.
Operating Margin history for Aerie Pharmaceuticals from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -38.23% | -82.13% |
| 2020 | -213.93% | -25.12% |
| 2019 | -285.70% | -70.29% |
| 2018 | -961.77% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -250.21% | 2,203.96% | 🇺🇸 USA |
 | -644.77% | 5,837.11% | 🇺🇸 USA |
 | 31.06% | -386.00% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.